Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

NET 1Endocrine 1CNS 1Breast 1

Conditions

Neuroma, Acoustic 1Neurofibromatosis 2 1Neuroendocrine Tumors 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 447Surgical Procedures, Operative 165Observation 152Drug Therapy 143Radiotherapy 142Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 79Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 67Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 62Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × 89Zr-bevacizumab × Clear all
NCT05685836 2024-03-20

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Leiden University Medical Center

Unknown
15 enrolled
CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01081613 2012-09-06

Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)

University Medical Center Groningen

Completed
7 enrolled
Breast

Breast Neoplasms

NCT01338090 2012-04-03

NETPET

University Medical Center Groningen

Completed
14 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡